NCT07515651
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
- Locations
-
- University Health Network - Princess Margaret Cancer Center Toronto, Ontario, Canada
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
434 public trials
103 recruiting studies
Adenocarcinoma trial results
Not Yet Recruiting
Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07507916
- Conditions
- Adenocarcinoma, Adjuvant Treatment, Carcinoma, +13 more
- Locations
-
Not specified
NCT07460726
- Conditions
- Adenocarcinoma, Carcinoma, Erectile Abnormalities, +18 more
- Locations
-
- Manitoba Prostate Centre Winnipeg, Manitoba, Canada
NCT07455422
- Conditions
- Adenocarcinoma, Adenocarcinoma - GEJ, Barrett Esophagus, +11 more
- Locations
-
- Antwerp University Hospital Edegem, Antwerpen, Belgium
- Sint-Augustinus Hospital (ZAS) Wilrijk, Antwerpen, Belgium
- Ghent University Hospital (UZ Gent) Ghent, Belgium
- AZ Delta Roeselare, Belgium
Not Yet Recruiting
Rezvilutamide for High-Risk Prostate Cancer After Surgery
NCT07444983
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
- Locations
-
- Department of Urology, Fujian Union Hospital, Fujian Medical University Fuzhou, Fujian, China
Not Yet Recruiting
Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer
NCT07368985
- Conditions
- Adenocarcinoma, Adenocarcinoma or Adeno-squamous Carcinoma Stage IB3-IIIC2, Carcinoma, +17 more
- Locations
-
- Erasmus MC Rotterdam, South Holland, Netherlands
Not Yet Recruiting
CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer
NCT07268794
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +14 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
NCT06942767
- Conditions
- Adenocarcinoma, Carcinoma, Gastric Adenocarcinoma, +4 more
- Locations
-
Not specified
Not Yet Recruiting
Evaluation of the PROSTia Test in Patients Undergoing Prostate Biopsy
NCT06931496
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
- Locations
-
- CHRU Nancy Vandœuvre-lès-Nancy, France
Not Yet Recruiting
Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.
NCT06855589
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
- Locations
-
- Hôpital de Gatineau Gatineau, Quebec, Canada
- Hôpital Charles LeMoyne Longueuil, Quebec, Canada
- Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
- Jewish General Hospital Montreal, Quebec, Canada